Given the incredible amounts of time and money invested in the specialty pharmacy market, it is important for key stakeholders to understand what medications are classified as specialty.
Discussions around domestic manufacturing of medical supplies have picked up steam in recent years as the COVID-19 pandemic highlighted the risks and challenges of the global supply chain.
Is your organization sourcing products and services independently or relying on years-old noncompetitive relationships? It might be high time to take a deeper look at your non-labor spend.
The hospital item master is the source of truth for supply chain and finance to assist in managing inventory — meaning it is crucial to understand some of the problems that can occur and how to combat them.
There is work underway that will begin to mitigate inpatient demand for pediatric behavioral health services later in the decade and drive steady outpatient growth across multiple sites. This includes the continued integration of behavioral health services...
Respiratory illness season has always been a challenge for healthcare organizations with additional admitted patients who require isolation, respiratory support, and at times intensive care unit beds.
Through meticulous selection, art consultants develop collections that can heal, encourage, uplift, calm and inspire. A positive patient, family, staff and visitor experience helps to reduce stress on healthcare leadership and promotes meaningful and impro...
Ashleigh Kervel outlines six ways healthcare leadership can leverage electronic health records (EHRs) to improve clinical practice and business decisions.
For more than 100 years, diagnostic imaging professionals from around the globe have reserved the week following Thanksgiving to attend the world's largest medical imaging convention in Chicago hosted by the Radiologic Society of North America.
After three years of the COVID-19 Public Health Emergency determination, Emily Jones outlines what healthcare providers need to know about deadlines, flexibilities, and the path ahead.
Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discuss the differences between these biosimilar products.
The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers.
You’ve made the effort to align your strategic sourcing and value analysis teams — but are you able to ensure continued success through the sustainability of these changes? Essential components of a sustainable program are strong value analysis and contrac...
In his latest blog posting entitled "College Basketball and National Health System Design” Vizient Research Institute executive director Tom Robertson describes an engaging exercise shared with audiences nationwide during 2022.
Effective management and preventative maintenance of diagnostic imaging and biomedical equipment can improve patient access to accurate diagnoses and effective treatment while increasing reliability and performance of medical assets within and across healt...
3PL vendors can leverage their expertise to create flexibility and offer enhanced sourcing strategies for providers. Whether a provider is supplementing their shared inventory strategy by stockpiling key products (like PPE) or seeking to engage in a turnke...
A look at the financial forces at work — and a few core strategies for health systems and life science and industry partners that may mitigate the negative economic environment’s impact.
Michael McCann and Walter Valliere outline the risk factors of chronic kidney disease and how people can make healthy lifestyle choices during the holidays and year-round to improve renal health.